EXCLUSIVE: Diagnostics Provider Avalon GloboCare's Subsidiary Launches New Laboratory Test For Tuberculosis
EXCLUSIVE: Diagnostics Provider Avalon GloboCare's Subsidiary Launches New Laboratory Test For Tuberculosis
Avalon GloboCare Corp (NASDAQ:ALBT) announced that Laboratory Services MSO (LSM) is now offering an in-house laboratory-developed test to detect tuberculosis using a patient's sputum sample.
Avalon GloboCare Corp 納斯達克股票代碼：ALBT）宣佈 實驗室服務 MSO (LSM) 現在提供一種內部實驗室開發的檢測方法，用於使用患者的痰液樣本檢測結核病。
Avalon owns a 40% interest in Laboratory Services (LSM).
Avalon擁有實驗室服務（LSM）40％的權益。
Laboratory Services' new PCR test allows for accurately and rapidly identifying Mycobacterium tuberculosis (Mtb) from samples.
實驗室服務的新型聚合酶鏈反應檢測允許從樣本中準確、快速地識別結核分枝桿菌（Mtb）。
Using sputum samples to detect Mtb provides easier collection and transport than blood samples in protein-based chemiluminescent immunoassays.
在基於蛋白質的化學發光免疫測定中，使用痰液樣本檢測 Mtb 比血液樣本更容易收集和運輸。
The most frequently used diagnostic methods for tuberculosis are the tuberculin skin test, acid-fast stain, culture, and polymerase chain reaction.
結核病最常用的診斷方法是結核菌素皮膚試驗、耐酸染色、培養和聚合酶鏈反應。
The skin test is a 120-year-old test that requires the patient to make repeat visits to the clinic, followed by a chest X-ray to confirm a positive test result.
皮膚檢查是一項已有120年曆史的測試，要求患者重複去診所，然後進行胸部X光檢查以確認陽性檢測結果。
The skin test takes several days to show a reaction. LSM's PCR-based test can be performed in under 2 hours, and the patient needs only one visit to the clinic to provide a sputum sample with no needle stick required.
皮膚測試需要幾天才能顯示出反應。LSM 基於 PCR 的檢測可以在不到 2 小時的時間內完成，患者只需到診所就診一次，即可提供痰液樣本，無需針棒。
Most frequently, TB affects the lungs. However, it can also cause disease in any part of the body. TB kills about 1.4 million people each year worldwide.
最常見的是，結核病會影響肺部。但是，它也可能導致身體任何部位的疾病。結核病每年在全球造成約140萬人死亡。
Price Action: ALBT shares closed at $0.94 on Tuesday.
價格走勢： ALBT股價週二收於0.94美元。
譯文內容由第三人軟體翻譯。